Clinical Trial Update: Immunotherapy and SBRT for Metastatic Head and Neck Carcinomas [Phase 1, Phase 2]

View source ↗

Summary

This entry describes a Phase 1/2 clinical trial investigating immunotherapy in combination with stereotactic body radiotherapy for metastatic head and neck squa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Squamous Cell Carcinoma

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Head and Neck Squamous Cell Carcinoma, Metastatic Squamous Cell Carcinoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING